Search
Company
Back
Who is Sysmex?
Back
Products
Back
Diagnostics
Back
Life Science
Back
Services
Back
QC & Online Services
Back
Document Centre
Back
Academy
Back
Knowledge Centre
Back
Career
Back
Why Sysmex
Back
Menu
Headquarters
Subsidiaries, Associated Foundation
Select your local website
News
Company news articles found here detail internal and external events that may be interesting for all stakeholders. Whether it’s CSR activities, product launches, collaborations or reports on events, you can stay up-to-date on the latest Sysmex news.
2020
2020/10/09 | Norderstedt, Germany
Sysmex Europe is celebrating 40 years of diagnostic advancement and growth
Sysmex Europe GmbH celebrates 40 years of business in EMEA and looks forward to continuing lighting the way with diagnostics.
more
2020/08/19
Updates & information on COVID-19
more
2020/07/14
Sysmex launches next-generation fully automated blood coagulation analysers CN-6000 and CN-3000 in EMEA
Power in a new dimension for the haemostasis laboratory
more
2020/07/03
Sysmex to Launch Novel Coronavirus (SARS-CoV-2) Antibody Lab Assay Service and Antibody Measurement Reagents (for Research)
Using the HISCL™-5000/HISCL™-800 Fully Automated Immunoassay Systems to Realize SARS-CoV-2 Antibody Detection
more
2020/07/03
The City of Kobe, Kobe City Medical Center General Hospital, and Sysmex Corporation Working to Launch from Kobe the Clinical Implementation of a New Test for the Novel Coronavirus
Collaborating with Medical Institutions of the Foundation for Biomedical Research and Innovation at Kobe to Strengthen Measures Allowing Early-Stage Diagnosis and Prediction of Severity
more
2020/07/03
The National Cancer Center, the National Center for Global Health and Medicine, and Sysmex Corporation Evaluatea SARS-CoV-2 Antibody Test with Support from the Japan Health Research Promotion Bureau
Performance Report onan Antibody Detection Reagent Using Clinical Specimens
more
2020/07/02
Sysmex Obtains First Marketing Approval in Japan for the Automated Hematology Analyzer XN-31 as a Class III Specially Controlled Medical Device to Diagnose Malaria
For Use as a Measure against Imported Infectious Diseases in Japan and Accelerating its Introduction to the Asian and African Markets
more
2020/05/29
OSNA label extension for cervical, endometrial and prostate cancer
more
2020/03/27
Sysmex Obtains First Marketing Approval in Japan for the Novel Coronavirus Nucleic Acid Detection Kits (RT-PCR Method)
Aiming for early introduction of test kits forin vitrodiagnostic medical devicesin medical institutions
-Japanese market only-
-Japanese market only-
more
2020/02/10
Magseed® magnetic marker approved for any soft tissue and long-term implantation across Europe
more
2020/01/14
Hitado GmbH becomes Nexus IB10 distributor for sphingotec in Germany and Switzerland
more
2020/01/14
Sysmex gives back – supporting social development together
more
2019
2019/12/20
OSNA for lung cancer – the newest addition to our oncology portfolio
more
2019/11/29
Sysmex Europe GmbH wins Silver Technology Award from the 2019 Learning In Practice Awards Program by Chief Learning Officer magazine.
more
2019/09/06
Sysmex Europe GmbH wins the Silver Award for ‘Best Customer Training Program’ from the 2019 Brandon Hall Group Excellence in Learning Awards
more
2019/08/29
Hamburg leaders visited Sysmex Corporation in Kobe
more
2019/06/13
A welcome addition to our portfolio: Sentinel’s SENTiFOB® analyser with new cap-piercing function, ideal for low-middle throughput, for the detection of faecal occult blood using FOBGold® reagents
more
2019/05/13
Sysmex Europe GmbH was awarded as ‘Top Employer SME 2019’ and ranked 8th in the category ‘Electronics and Electrical Engineering, Medical Devices’
more
2018
2018/12/04
Sysmex Europe GmbH organises a blood donation and sport event on 3 December
more
2018/10/26
Congratulations to our CEO Hisashi Ietsugu!
more
2018/02/08
Sysmex Middle East in Medlab exhibition 5-8 February 2018 in Dubai- UAE
Sysmex is creating new opportunities, involving more and more stakeholders, and increasingly getting to the root of the core issues our healthcare clients face.
more
